APA (7th ed.) Citation

R, D., J, Z., RV, L., S, T., JT, A., MA, C., . . . AB, H. (2025). Is modulation of immune checkpoints on glioblastoma-infiltrating myeloid cells a viable therapeutic strategy? Neuro-oncology, 27(1), 33. https://doi.org/10.1093/neuonc/noae193

Chicago Style (17th ed.) Citation

R, Du, et al. "Is Modulation of Immune Checkpoints on Glioblastoma-infiltrating Myeloid Cells a Viable Therapeutic Strategy?" Neuro-oncology 27, no. 1 (2025): 33. https://doi.org/10.1093/neuonc/noae193.

MLA (9th ed.) Citation

R, Du, et al. "Is Modulation of Immune Checkpoints on Glioblastoma-infiltrating Myeloid Cells a Viable Therapeutic Strategy?" Neuro-oncology, vol. 27, no. 1, 2025, p. 33, https://doi.org/10.1093/neuonc/noae193.